Axsome Therapeutics, Inc.

Pharmaceutical Preparations·NEW YORK, NY·FY end 12/31·CIK 1579428

Overview Financials Compensation Governance Insiders Filings

Named Executive Officers

FY 2025

Executive	Salary	Stock	Options	Bonus / Inc.	Other	Total
Herriot Tabuteau, M.D.Chief Executive Officer and Chairman of the Board	—	—	—	—	—	$33.8M
Herriot TabuteauM.D.	$835.0K	$5.5M	$2.8M	$876.8K	$205.0K	$10.3M
Mark JacobsonM.A.	$575.0K	$2.1M	$1.1M	$388.0K	$95.6K	$4.2M
Nick PizzieC.P.A., M.B.A.	$530.0K	$1.8M	$933.3K	$358.0K	$86.6K	$3.7M
General Counsel	$505.0K	$766.5K	$1.5M	$398.0K	$42.7K	$3.2M
Hunter MurdockEsq.	$530.0K	$1.5M	$766.6K	$358.0K	$72.6K	$3.2M
Ari MaizelM.B.A.	$530.0K	$1.5M	$766.6K	$358.0K	$37.0K	$3.2M
Hunter Murdock, Esq.	—	—	—	—	—	—
Mark Jacobson, M.A.	—	—	—	—	—	—
Ari Maizel, M.B.A.	—	—	—	—	—	—
Nick Pizzie, C.P.A., M.B.A. · CFO	—	—	—	—	—	—

CEO pay mix

Herriot Tabuteau, M.D. · FY 2025

Performance vs. pay

Item 402(v) Pay-Versus-Performance disclosure data not yet ingested for this company. Mandatory only for FYs ending on/after Dec 16, 2022 — older companies may not have filed it yet.

CEO comp · median worker · ratio — 5-year trend

CEO total compMedian employeePay ratio (right axis)